Tingwei Peng
Qing Liu2†
Xue Wang
Ping Ru
Tianzhao Xu
Xinghui Liu
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, China
- 2Department of Clinical Laboratory, Shanghai Gongli Hospital, The Second Military Medical University, Shanghai, China
- 3Department of Obstetrics, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
- 4Hospital Department, Shanghai University of Medicine and Health Sciences Affiliated to Zhoupu Hospital, Shanghai, China
by Peng T, Liu Q, Song H, Zhang C, Wang X, Ru P, Xu T and Liu X (2023), Front. Bioeng. Biotechnol. 11:1151148. doi: 10.3389/fbioe.2023.1151148
In the published article, there was an error in Figure 6A as published. The photograph of nude mouse is wrong in hmSeO2@ICG-RGD group. The corrected Figure 6 and its caption appear below.
FIGURE 6
FIGURE 6. (A) Representative photographs of breast carcinoma-bearing BALB/c nude mice 0, 7 and 15 days after various treatments. (B) Representative resected tumors from mice in the various groups 15 days after treatment administration. (C) Tumor volumes in mice following various treatments. (D) Tumor weights after 15 days of treatment. **p < 0.01. (E) Body weights of mice in each treatment group. (F) H&E and TUNEL-staining photographs of tumor tissues resected from subcutaneous tumor-bearing mice after various treatments for 7 days.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hollowed mesoporous SeO2, ICG precise delivery, NIR II fluorescent imaging, photothermal therapy, ROS mediated oxidative therapy
Citation: Peng T, Liu Q, Song H, Zhang C, Wang X, Ru P, Xu T and Liu X (2023) Corrigendum: Biodegradable hollowed mesoporous SeO2 nanoplatform loaded with indocyanine green for simultaneous NIR II fluorescence imaging and synergistic breast carcinoma therapy. Front. Bioeng. Biotechnol. 11:1201751. doi: 10.3389/fbioe.2023.1201751
Received: 07 April 2023; Accepted: 13 April 2023;
Published: 20 April 2023.
Edited and reviewed by:
Hongcheng Sun, Hangzhou Normal University, ChinaCopyright © 2023 Peng, Liu, Song, Zhang, Wang, Ru, Xu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ping Ru, cnVwaW5nX3JwQDE2My5jb20=; Xinghui Liu, c3lsaXV4aEAxNjMuY29t; Tianzhao Xu, dGlhbnpoYW94dWZhbkAxNjMuY29t
†These authors have contributed equally to this work